BioLineRx (BLRX) Enterprise Value (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.62% |
| Sep 30, 2025 | 19.72% |
| Jun 30, 2025 | -19.10% |
| Mar 31, 2025 | -34.80% |
| Dec 31, 2024 | 32.94% |
| Sep 30, 2024 | 15.91% |
| Jun 30, 2024 | -23.14% |
| Mar 31, 2024 | 34.47% |
| Dec 31, 2023 | -65.57% |
| Sep 30, 2023 | 22.01% |
| Jun 30, 2023 | 23.08% |
| Mar 31, 2023 | 15.26% |
| Dec 31, 2022 | 10.61% |
| Sep 30, 2022 | -35.63% |
| Jun 30, 2022 | 16.71% |
| Mar 31, 2022 | 11.46% |
| Dec 31, 2021 | 12.04% |
| Sep 30, 2021 | 0.93% |
| Jun 30, 2021 | -12.89% |
| Mar 31, 2021 | -157.15% |
| Dec 31, 2020 | -15.40% |
| Sep 30, 2020 | 27.71% |
| Jun 30, 2020 | -27.83% |
| Mar 31, 2020 | 22.95% |
| Dec 31, 2019 | 8.80% |
| Sep 30, 2019 | 14.44% |
| Jun 30, 2019 | 13.25% |
| Mar 31, 2019 | -34.68% |
| Dec 31, 2018 | 13.86% |
| Sep 30, 2018 | 13.46% |
| Jun 30, 2018 | 8.48% |
| Mar 31, 2018 | 10.68% |
| Dec 31, 2017 | 10.04% |
| Sep 30, 2017 | -4.65% |
| Jun 30, 2017 | -73.08% |
| Mar 31, 2017 | 14.75% |
| Dec 31, 2016 | 8.44% |
| Sep 30, 2016 | 6.97% |
| Jun 30, 2016 | 7.08% |
| Mar 31, 2016 | 5.57% |
| Dec 31, 2015 | 6.00% |
| Sep 30, 2015 | 7.45% |
| Jun 30, 2015 | 4.70% |
| Mar 31, 2015 | -65.78% |
| Dec 31, 2014 | -17.23% |
| Sep 30, 2014 | 10.75% |
| Jun 30, 2014 | 11.59% |
| Mar 31, 2014 | -105.80% |
| Dec 31, 2013 | 10.07% |
| Sep 30, 2013 | 12.20% |
| Jun 30, 2013 | 17.84% |
| Mar 31, 2013 | -135.47% |